Drug Side Effects
Search
CSF VIRUS IDENTIFIED
CSF VIRUS IDENTIFIED
was reported 70 times
CSF VIRUS IDENTIFIED is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Benzothiazole [EPC]
1
0.0004
1
CCR5 Co-receptor Antagonist [EPC]
1
0.0004
2
Rifamycin Antimycobacterial [EPC]
1
0.0003
3
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
27
0.0002
4
Cytochrome P450 3A Inhibitor [EPC]
12
0.0002
5
Protease Inhibitor [EPC]
8
0.0002
6
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
3
0.0001
7
Calcineurin Inhibitor Immunosuppressant [EPC]
7
0.0001
8
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
5
0.0000
9
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
2
0.0000
10
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
4
0.0000
11
Macrolide Antimicrobial [EPC]
1
0.0000
12
Aromatase Inhibitor [EPC]
2
0.0000
13
Alkylating Drug [EPC]
4
0.0000
14
Folate Analog Metabolic Inhibitor [EPC]
6
0.0000
15
Topoisomerase Inhibitor [EPC]
1
0.0000
16
Integrin Receptor Antagonist [EPC]
1
0.0000
17
alpha-Adrenergic Blocker [EPC]
1
0.0000
18
Azole Antifungal [EPC]
1
0.0000
19
Janus Kinase Inhibitor [EPC]
1
0.0000
20
Interferon beta [EPC]
1
0.0000
21
Proton Pump Inhibitor [EPC]
3
0.0000
22
Retinoid [EPC]
1
0.0000
23
Corticosteroid [EPC]
5
0.0000
24
Platinum-based Drug [EPC]
1
0.0000
25
Kinase Inhibitor [EPC]
2
0.0000
26
beta-Adrenergic Blocker [EPC]
1
0.0000
27
CD20-directed Cytolytic Antibody [EPC]
1
0.0000
28
HMG-CoA Reductase Inhibitor [EPC]
1
0.0000
29
Vitamin C [EPC]
1
0.0000
30
Tumor Necrosis Factor Blocker [EPC]
1
0.0000